Parallel trade in the pharmaceutical market: current trends and future solutions.
Parallel trade in the pharmaceutical market: current trends and future solutions.
This article explores the relationship between EU law and the pharmaceutical market. It analyses the political debate on the competitiveness of the European pharmaceutical industry, in the view of the enlargement, the different models of regulation of pharmaceuticals in the Member States and the economic theories of parallel trade and intellectual property rights. Against this background, it is demonstrated that both the Commission and the Court of Justice have adopted a strong pro-single market approach, whereby price regulations, ethical obligations to sell medicines and the need for adequate reward of investment in research and development have been considered incapable of limiting the scope of application of the European law of competition and free movement of goods. The article suggests solutions available under the existing legal framework; it also proposes, in view of further European harmonisation, the principle of effective and fair negotiation as a core element in price regulation in the Member States.
53-74
Nazzini, Renato
ac9354d4-5b96-408a-9ef0-f398776b153f
2003
Nazzini, Renato
ac9354d4-5b96-408a-9ef0-f398776b153f
Nazzini, Renato
(2003)
Parallel trade in the pharmaceutical market: current trends and future solutions.
World Competition, 26 (1), .
Abstract
This article explores the relationship between EU law and the pharmaceutical market. It analyses the political debate on the competitiveness of the European pharmaceutical industry, in the view of the enlargement, the different models of regulation of pharmaceuticals in the Member States and the economic theories of parallel trade and intellectual property rights. Against this background, it is demonstrated that both the Commission and the Court of Justice have adopted a strong pro-single market approach, whereby price regulations, ethical obligations to sell medicines and the need for adequate reward of investment in research and development have been considered incapable of limiting the scope of application of the European law of competition and free movement of goods. The article suggests solutions available under the existing legal framework; it also proposes, in view of further European harmonisation, the principle of effective and fair negotiation as a core element in price regulation in the Member States.
This record has no associated files available for download.
More information
Published date: 2003
Identifiers
Local EPrints ID: 42069
URI: http://eprints.soton.ac.uk/id/eprint/42069
ISSN: 1011-4548
PURE UUID: 7d52179c-3f50-4942-becd-e8f5b75a2f27
Catalogue record
Date deposited: 14 Nov 2006
Last modified: 11 Dec 2021 16:03
Export record
Contributors
Author:
Renato Nazzini
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics